Home Cart Sign in  
Chemical Structure| 1192491-61-4 Chemical Structure| 1192491-61-4

Structure of Avibactam sodium
CAS No.: 1192491-61-4

Chemical Structure| 1192491-61-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Avibactam sodium (NXL-104) is a covalent and reversible non-β-lactam β-lactamase inhibitor, inhibiting β-lactamase TEM-1 and CTX-M-15 with IC50 values of 8 nM and 5 nM, respectively.

Synonyms: NXL-104; Avibactam (sodium salt); AVE-1330A

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Farooq, Aneeq ; Drotleff, Bernhard ; Kroemer, Niklas ; Han, Mei-Ling ; Li, Jian ; Decousser, Jean Winoc , et al.

Abstract: Background: Combination therapy offers a promising option to enhance efficacy and prevent resistance. A comprehensive and quantitative assessment of the last-resort combination of ceftazidime/avibactam and tigecycline is not available. Objective: This study systematically investigated the pharmacodynamic interaction between ceftazidime/avibactam and tigecycline in clinical and isogenic Escherichia coli and Klebsiella pneumoniae strains harbouring genes that encode various carbapenemases or ESBLs. Methods: An adaptive in vitro 'dynamic' checkerboard design and pharmacometric modelling were employed for the evaluation of pharmacodynamic interactions in fifteen bacterial isolates. Additionally, time-kill assays and metabolomic analyses were used to provide mechanistic insights. Results: Antagonistic drug interactions between ceftazidime/avibactam and tigecycline were identified in the majority of tested strains. Time-kill assays confirmed antagonistic interactions, with tigecycline limiting ceftazidime/avibactam total killing. Metabolomic analyses of mono and combined drug exposure to bacteria revealed matching metabolomes in tigecycline alone and the combination with ceftazidime/avibactam, corroborating the identified antagonism between these drugs. Conclusions: Our study reveals that the antagonistic interaction between ceftazidime/avibactam and tigecycline can undermine ceftazidime/avibactam's efficacy, suggesting limited clinical benefit in combining these antibiotics. Therefore, further research is encouraged to explore this and alternative combinations or approaches that may offer better clinical outcomes.

Purchased from AmBeed:

Alternative Products

Product Details of Avibactam sodium

CAS No. :1192491-61-4
Formula : C7H10N3NaO6S
M.W : 287.23
SMILES Code : O=S(ON1[C@]2([H])CC[C@@H](C(N)=O)[N@@](C2)C1=O)([O-])=O.[Na+]
Synonyms :
NXL-104; Avibactam (sodium salt); AVE-1330A
MDL No. :MFCD28900719
InChI Key :RTCIKUMODPANKX-JBUOLDKXSA-M
Pubchem ID :24944097

Safety of Avibactam sodium

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.48mL

0.70mL

0.35mL

17.41mL

3.48mL

1.74mL

34.82mL

6.96mL

3.48mL

References

 

Historical Records

Categories